Objective To evaluate the comparative efficacy and safety of glucagon-like peptide-1
receptor agonists (GLP-1RAs) on glycaemic control, body weight, and lipid profile in adults …

Background Comparative effectiveness of 7 glucagon-like peptide 1 (GLP-1) agents on
weight loss (WL) in obesity remains unknown. Methods We performed a systematic review …

It is known that nitric oxide (NO) plays a key physiological role in the control of
gastrointestinal (GI) motor phenomena. In this respect, NO is considered as the main non …

Abstract Objective Metabolic Syndrome, which can be induced or exacerbated by current
antipsychotic drugs (APDs), is highly prevalent in schizophrenia patients. Recent preclinical …

Background Previous studies supported that dietary factor was associated with constipation,
but the relationship between dietary energy intake and constipation has not been well …

Abstract Background Metabolic syndrome (MetS), which can be induced or exacerbated by
the current class of antipsychotic drugs, is highly prevalent in patients with schizophrenia …

Older patients are prone to multimorbidity or related polypharmacy, which may cause
various adverse drug reactions (ADRs) and a high incidence of drug‐related health …

Purpose To explore the relationships between serum tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP) levels and glucolipid …

Aim To identify patient factors, including gastrointestinal functions, that are predictive or
associated with weight loss in response to once‐daily 3 mg liraglutide administered …

Recently, there have been several important contributions published in GUT on the role of
glycaemic control and glucagonlike peptide-1 (GLP-1) receptor agonists (RAs) in diverse …